2m 2m 2m 2m 2m 2m 2m
ABCELLERA BIOLOG (ABCL)
NASDAQ
$13.80-$0.11 (-0.80%)
Price as of Oct 02, 2026 5:46 PM EDT- $4.5BMarket Cap
- 132.61%1-Year Change
- BiotechnologyIndustry
ABCELLERA BIOLOG (ABCL)
$13.80-$0.11 (-0.80%)
ABCL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.91 | ||
Change | -$0.68 (-4.66%) | ||
Open | $14.59 | ||
High | $14.65 | ||
Low | $13.79 | ||
Previous Close | $14.59 | ||
Volume | 7,788,587 | ||
30-Day Average Volume | 4,741,907 | ||
1-Week Change | 9.96% | ||
1-Month Change | 23.32% | ||
1-Year Change | 132.61% | ||
3-Year Change | 202.39% | ||
5-Year Change | -19.13% | ||
Fundamentals | |||
Shares Outstanding | 324.0M | ||
Total Assets | $1.3B | ||
Market Cap | $4.5B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $3.9M | ||
Net Income | -$55.4M | ||
Free Cash Flow | $23.8M | ||
EBIT | -$58.9M | ||
EBITDA | -$58.0M | ||
Net Working Capital | $626.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | 1,140 | ||
P/B | 5 | ||
P/E | -77 | ||
PEG | 3 | ||
Price/Free Cash Flow | 189 | ||
Price/Operating Cash Flow | 174 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue